Logo image of LEAP

Ribbit LEAP Ltd (LEAP) Stock Fundamental Analysis

USA - NYSE:LEAP - KYG7552B1059 - Common Stock

10.02 USD
0 (0%)
Last: 8/12/2022, 9:08:23 PM
10.02 USD
0 (0%)
After Hours: 8/12/2022, 9:08:23 PM
Fundamental Rating

3

Overall LEAP gets a fundamental rating of 3 out of 10. We evaluated LEAP against 0 industry peers in the Unkown industry. While LEAP has a great health rating, there are worries on its profitability. LEAP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LEAP was profitable.
LEAP Yearly Net Income VS EBIT VS OCF VS FCFLEAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 25.6%
ROE 26.89%
ROIC -0.2%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LEAP Yearly ROA, ROE, ROICLEAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LEAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LEAP Yearly Profit, Operating, Gross MarginsLEAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LEAP is destroying value.
The number of shares outstanding for LEAP remains at a similar level compared to 1 year ago.
LEAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LEAP Yearly Shares OutstandingLEAP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M 40M 50M
LEAP Yearly Total Debt VS Total AssetsLEAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

LEAP has an Altman-Z score of 14.15. This indicates that LEAP is financially healthy and has little risk of bankruptcy at the moment.
LEAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.15
ROIC/WACC-0.02
WACC8.71%
LEAP Yearly LT Debt VS Equity VS FCFLEAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 100M 200M 300M

2.3 Liquidity

LEAP has a Current Ratio of 2.64. This indicates that LEAP is financially healthy and has no problem in meeting its short term obligations.
LEAP has a Quick Ratio of 2.64. This indicates that LEAP is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
LEAP Yearly Current Assets VS Current LiabilitesLEAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 215.81% over the past year.
EPS 1Y (TTM)215.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.43, which indicates a rather cheap valuation of LEAP.
LEAP is valuated cheaply when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.43
Fwd PE N/A
LEAP Price Earnings VS Forward Price EarningsLEAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LEAP Per share dataLEAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LEAP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Ribbit LEAP Ltd

NYSE:LEAP (8/12/2022, 9:08:23 PM)

After market: 10.02 0 (0%)

10.02

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.25%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap458.19M
Analysts55.8
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.43
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.26
EY22.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS8.4
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 25.6%
ROE 26.89%
ROCE N/A
ROIC -0.2%
ROICexc N/A
ROICexgc -0.2%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 14.15
F-Score4
WACC8.71%
ROIC/WACC-0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A